Avinger says expands U.S. reach with seven new accounts in Q3
Avinger announced the launch of seven new Lumivascular centers during the third quarter, including sites in the high-volume PAD markets of Florida, Georgia and Arizona. "We are excited to report the launch of seven new clinical centers using Avinger's best-in-class Lumivascular platform during the third quarter, as we continue to expand our geographic reach in the U.S. and bring highly differentiated new products to market," said Jeff Soinski, Avinger's President and CEO. "Clinical outcomes consistently show that our unique combination of real-time intravascular imaging with directional atherectomy allows physicians to provide precise and highly effective therapy for their patients with PAD. These outcomes are driving market excitement across our entire product platform, including our new Pantheris SV device."